AI assistant
Sending…
RESMED INC — Director's Dealing 2020
Dec 2, 2020
30071_dirs_2020-12-01_96332dd8-335f-472d-a1e8-c8a9cfede61b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-19
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-19 | ResMed Common Stock Options | $211.76 | A | 20776 | Acquired | 2027-11-19 | ResMed Common Stock (20776) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 215358 | Indirect |
| ResMed Common Stock | 12603 | Direct |
Footnotes
F1: Corrects original reported option grant for updated Black-Scholes valuation.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29